Rikki Lynn Seeberger, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-3322 |
Amy Payne Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2139 Bluehills Rd, Manhattan, KS 66502 Phone: 785-272-1535 |
Anna M Jaros, MOT OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1133 College Ave Ste E230, Manhattan, KS 66502 Phone: 785-587-1825 Fax: 785-587-1828 |
Dr. Emily Ann Lehman, OTD, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1133 College Ave Ste E230, Manhattan, KS 66502 Phone: 785-587-1825 |
Sheri D. Mahan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 455 E Poyntz, Mercy Regional Health Center, Manhattan, KS 66502 Phone: 785-587-4220 Fax: 785-539-9473 |
News Archive
Recession-driven budget cuts by hospitals and governmental entities reduced sales for Allied Healthcare Products, Inc. throughout fiscal 2010. The company managed to offset much of the year's sales decline by cutting overhead and operating costs. Still, the company reported a loss for the year.
Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,655,221 (the '221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
A new study has shed light on the role fatty acids play in Parkinson's disease and pointed towards an enzyme as a potential therapeutic target for the disease.
› Verified 1 days ago